Butterfly Network, Inc.

NYSE:BFLY

Medical - Devices

Healthcare
$6.08 +32.84%

+$1.88 today

Market cap
$1.63B
Beta
2.20
P/E (TTM)
-25.7
EPS (TTM)
-$0.30
52W Low $1.32High $8.01

Volume 4.78M

Average 4.92M

BFLY Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Butterfly Network, Inc.NYSE: BFLY

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses dips below year-ago levels

Q1 FY2026 other income / expenses of $811K fell 82.0% year over year, behind the +4.2% change in trailing-twelve-month other income / expenses. Sequentially, it fell 80.9% from the prior quarter. Over 3 fiscal years it compounded at -27.0% a year.

Context

  • Other income / expenses amounted to 9.7% of revenue in FY2025, up 7.4 pp from a year earlier.
  • Other income / expenses increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -82.0% toward the trailing-twelve-month pace of +4.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$811K-80.9% QoQ
Last fiscal yearDec 2025
$9.46M+401.4% YoY
LTMMar 2026
$5.76M+4.2% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-82.0%——
1 year+401.4%——
3-year CAGR-27.0%——
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
9.46M USD
Year-over-year change
+401.4%
4-year CAGR
-50.7%

Other Income / Expenses vs competitors

How BFLY compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +4.2% is the 3rd highest of 9, against a peer median of -31.8%.
  • Other income / expenses amounts to 5.6% of revenue for BFLY, versus a peer median of 14.5%.
BFLY Competitors
Other Income / Expenses for BFLY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PACBPacific Biosciences of California, Inc.LTM Mar 2026$35.01M USD-78.7%—21.9%
ARVNArvinas, Inc.LTM Mar 2026$28.7M USD-42.1%+178.1%32.1%
FLGTFulgent Genetics, Inc.LTM Mar 2026$23.01M USD+2.7%+56.5%7.2%
BFLYButterfly Network, Inc.LTM Mar 2026$5.76M USD+4.2%-27.0%5.6%
SIBNSI-BONE, Inc.LTM Mar 2026$3.24M USD-21.6%—1.6%
AMNAMN Healthcare Services, Inc.LTM Mar 2026-$841K USD+98.7%—0.0%
OFIXOrthofix Medical Inc.LTM Mar 2026-$26.23M USD+28.5%—3.2%
VALNValneva SELTM Mar 2026-€38.24M EUR-120.8%—24.5%
EVHEvolent Health, Inc.LTM Mar 2026-$480.92M USD-495.4%—25.5%
Peer median (excluding BFLY) —-31.8%+117.3%14.5%

Competitors are the stored peer set for BFLY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue62.57M73.39M65.9M82.06M97.61M
Cost of Revenue45.51M33.93M49.04M33.23M51.88M
Gross Profit17.05M39.46M16.86M48.83M45.73M
Gross Margin27.3%53.8%25.6%59.5%46.9%
Research & Development74.46M88.04M55.62M37.8M36.26M
Selling, General & Admin135.32M144.44M106.85M85.44M85.11M
Operating Expenses209.78M232.48M162.47M123.24M132.15M
Depreciation & Amortization2.09M5.94M10.57M10.34M8.08M
EBITDA(29.55M)(162.74M)(123.04M)(60.92M)(67.38M)
EBITDA Margin-47.2%-221.8%-186.7%-74.2%-69.0%
Operating Income(192.73M)(193.02M)(145.61M)(74.41M)(86.42M)
Operating Margin-308.0%-263.0%-221.0%-90.7%-88.5%
Interest Income2.57M3.38M7.45M5.02M5.91M
Interest Expense651K2K01.26M1.49M
Other Income / Expenses160.44M24.34M11.99M1.89M9.46M
Income Before Tax(32.29M)(168.68M)(133.62M)(72.52M)(76.95M)
Pre-Tax Margin-51.6%-229.8%-202.8%-88.4%-78.8%
Income Tax Expense121K42K82K(32K)110K
Net Income(32.41M)(168.72M)(133.7M)(72.49M)(77.06M)
Net Margin-51.8%-229.9%-202.9%-88.3%-79.0%
EPS (Basic)(0.19)(0.84)(0.65)(0.34)(0.31)
EPS (Diluted)(0.19)(0.84)(0.65)(0.34)(0.31)
Weighted Avg Shares173.81M199.85M205.39M211.68M247.12M
Weighted Avg Shares (Diluted)173.81M199.85M205.39M211.68M247.12M

Butterfly Network, Inc.

NYSE:BFLY

Intrinsic Alpha fair value

Locked

Current Price

$6.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.